293 related articles for article (PubMed ID: 24737580)
1. Selective impairment of attention networks in breast cancer patients receiving chemotherapy treatment.
Chen X; Li J; Ren J; Hu X; Zhu C; Tian Y; Hu P; Ma H; Yu F; Wang K
Psychooncology; 2014 Oct; 23(10):1165-71. PubMed ID: 24737580
[TBL] [Abstract][Full Text] [Related]
2. Dissociation of decision making under ambiguity and decision making under risk in breast cancer patients receiving adjuvant chemotherapy: a neuropsychological study.
Chen X; Zhu C; Li J; Qiu L; Zhang L; Yu F; Ye R; Zhang J; Wang K
Brain Res; 2013 Oct; 1533():63-72. PubMed ID: 23954744
[TBL] [Abstract][Full Text] [Related]
3. [Cognitive function in breast cancer patients on chemotherapy: a longitudinal study].
Chen X; Li J; Zhu C; Li D; Zhang J; Wang K
Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(1):27-30. PubMed ID: 24721302
[TBL] [Abstract][Full Text] [Related]
4. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.
Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Gundy C; Schagen SB
J Clin Oncol; 2012 Apr; 30(10):1080-6. PubMed ID: 22370315
[TBL] [Abstract][Full Text] [Related]
5. Cognitive deficits in Korean women treated with chemotherapy for breast cancer.
Jung MS; Cimprich B
Cancer Nurs; 2014; 37(3):E31-42. PubMed ID: 23945143
[TBL] [Abstract][Full Text] [Related]
6. Selective impairment of attention networks during propofol anesthesia after gynecological surgery in middle-aged women.
Chen C; Xu GH; Li YH; Tang WX; Wang K
J Neurol Sci; 2016 Apr; 363():126-31. PubMed ID: 27000237
[TBL] [Abstract][Full Text] [Related]
7. Impairment of the executive attention network in premenopausal women with hormone receptor-positive breast cancer treated with tamoxifen.
Chen X; Li J; Zhang J; He X; Zhu C; Zhang L; Hu X; Wang K
Psychoneuroendocrinology; 2017 Jan; 75():116-123. PubMed ID: 27815995
[TBL] [Abstract][Full Text] [Related]
8. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
[TBL] [Abstract][Full Text] [Related]
9. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature.
Falleti MG; Sanfilippo A; Maruff P; Weih L; Phillips KA
Brain Cogn; 2005 Oct; 59(1):60-70. PubMed ID: 15975700
[TBL] [Abstract][Full Text] [Related]
10. Selective impairment of attentional networks of orienting and executive control in schizophrenia.
Wang K; Fan J; Dong Y; Wang CQ; Lee TM; Posner MI
Schizophr Res; 2005 Oct; 78(2-3):235-41. PubMed ID: 16154056
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy-induced prospective memory impairment in patients with breast cancer.
Cheng H; Yang Z; Dong B; Chen C; Zhang M; Huang Z; Chen Z; Wang K
Psychooncology; 2013 Oct; 22(10):2391-5. PubMed ID: 23674402
[TBL] [Abstract][Full Text] [Related]
12. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
Castellon SA; Ganz PA; Bower JE; Petersen L; Abraham L; Greendale GA
J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545
[TBL] [Abstract][Full Text] [Related]
13. The attention network changes in breast cancer patients receiving neoadjuvant chemotherapy: Evidence from an arterial spin labeling perfusion study.
Chen X; He X; Tao L; Cheng H; Li J; Zhang J; Qiu B; Yu Y; Wang K
Sci Rep; 2017 Feb; 7():42684. PubMed ID: 28209975
[TBL] [Abstract][Full Text] [Related]
14. Selective attentional deficit in essential tremor: Evidence from the attention network test.
Pauletti C; Mannarelli D; De Lucia MC; Locuratolo N; Currà A; Missori P; Marinelli L; Fattapposta F
Parkinsonism Relat Disord; 2015 Nov; 21(11):1306-11. PubMed ID: 26365776
[TBL] [Abstract][Full Text] [Related]
15. Analysis of memory deficits following chemotherapy in breast cancer survivors: evidence from the doors and people test.
Prokasheva S; Faran Y; Cwikel J; Geffen DB
J Psychosoc Oncol; 2011; 29(5):499-514. PubMed ID: 21882931
[TBL] [Abstract][Full Text] [Related]
16. Cognitive function in women with breast cancer receiving adjuvant chemotherapy and healthy controls.
Ando-Tanabe N; Iwamitsu Y; Kuranami M; Okazaki S; Yasuda H; Nakatani Y; Yamamoto K; Watanabe M; Miyaoka H
Breast Cancer; 2014 Jul; 21(4):453-62. PubMed ID: 22976288
[TBL] [Abstract][Full Text] [Related]
17. Phasic and tonic alerting in mild cognitive impairment: A preliminary study.
Martella D; Manzanares S; Campoy G; Roca J; Antúnez C; Fuentes LJ
Exp Gerontol; 2014 Jan; 49():35-9. PubMed ID: 24252535
[TBL] [Abstract][Full Text] [Related]
18. Impairment of attention networks in patients with untreated hyperthyroidism.
Yuan L; Tian Y; Zhang F; Dai F; Luo L; Fan J; Wang K
Neurosci Lett; 2014 Jun; 574():26-30. PubMed ID: 24852828
[TBL] [Abstract][Full Text] [Related]
19. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer.
Tchen N; Juffs HG; Downie FP; Yi QL; Hu H; Chemerynsky I; Clemons M; Crump M; Goss PE; Warr D; Tweedale ME; Tannock IF
J Clin Oncol; 2003 Nov; 21(22):4175-83. PubMed ID: 14615445
[TBL] [Abstract][Full Text] [Related]
20. Cognitive effects of chemotherapy in breast cancer patients: a dose-response study.
Collins B; MacKenzie J; Tasca GA; Scherling C; Smith A
Psychooncology; 2013 Jul; 22(7):1517-27. PubMed ID: 22936651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
